These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 30228093)

  • 1. Interleukin-12p35 Knock Out Aggravates Doxorubicin-Induced Cardiac Injury and Dysfunction by Aggravating the Inflammatory Response, Oxidative Stress, Apoptosis and Autophagy in Mice.
    Ye J; Huang Y; Que B; Chang C; Liu W; Hu H; Liu L; Shi Y; Wang Y; Wang M; Zeng T; Zhen W; Xu Y; Shi L; Liu J; Jiang H; Ye D; Lin Y; Wan J; Ji Q
    EBioMedicine; 2018 Sep; 35():29-39. PubMed ID: 30228093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-12p35 knockout promotes macrophage differentiation, aggravates vascular dysfunction, and elevates blood pressure in angiotensin II-infused mice.
    Ye J; Que B; Huang Y; Lin Y; Chen J; Liu L; Shi Y; Wang Y; Wang M; Zeng T; Wang Z; Hu H; Xu Y; Shi L; Ye D; Liu J; Jiang H; Wan J; Ji Q
    Cardiovasc Res; 2019 May; 115(6):1102-1113. PubMed ID: 30395167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-12p35 deficiency enhances mitochondrial dysfunction and aggravates cardiac remodeling in aging mice.
    Ye J; Wang Y; Wang Z; Liu L; Yang Z; Ye D; Wang M; Xu Y; Zhang J; Zhao M; Liu J; Lin Y; Ji Q; Wan J
    Aging (Albany NY); 2020 Jan; 12(1):193-203. PubMed ID: 31901899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-interleukin-5-neutralizing antibody attenuates caradiac injury and cadiac dysfunction by aggravating the inflammatory response in doxorubicin-treated mice.
    Xian D; Zhan Y; Yang Z; Fan C; Liu L; Lin Y
    Cell Biol Int; 2020 Jun; 44(6):1363-1372. PubMed ID: 32125042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-22 deficiency alleviates doxorubicin-induced oxidative stress and cardiac injury via the p38 MAPK/macrophage/Fizz3 axis in mice.
    Ye J; Wang Y; Xu Y; Wang Z; Liu L; Wang M; Ye D; Zhang J; Yang Z; Lin Y; Ji Q; Wan J
    Redox Biol; 2020 Sep; 36():101636. PubMed ID: 32863209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-27p28 knockout aggravates Doxorubicin-induced cardiotoxicity by regulating Macrophage polarization.
    Feng Y; Ji Q; Ye D; Pan H; Lu X; Gan L; Wang M; Liu J; Xu Y; Zhang J; Zhao M; Xu S; Yin Z; Pan W; Wei C; Liu M; Wan J; Ye J
    Biochem Pharmacol; 2023 Apr; 210():115469. PubMed ID: 36868324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling.
    Zhang J; Wang M; Ding W; Zhao M; Ye J; Xu Y; Wang Z; Ye D; Li D; Liu J; Wan J
    Biochem Pharmacol; 2020 Oct; 180():114188. PubMed ID: 32750329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of IL-12p35 improves cardiac repair after myocardial infarction by promoting angiogenesis.
    Kan X; Wu Y; Ma Y; Zhang C; Li P; Wu L; Zhang S; Li Y; Du J
    Cardiovasc Res; 2016 Feb; 109(2):249-59. PubMed ID: 26614777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-9 aggravates doxorubicin-induced cardiotoxicity by promoting inflammation and apoptosis in mice.
    Ye D; Wang Z; Xu Y; Ye J; Wang M; Liu J; Zhang J; Zhao M; Chen J; Wan J
    Life Sci; 2020 Aug; 255():117844. PubMed ID: 32464124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Interleukin-16-Neutralizing Antibody Attenuates Cardiac Inflammation and Protects against Cardiac Injury in Doxorubicin-Treated Mice.
    Zhang J; Yang Z; Liang Z; Wang M; Hu C; Chang C; Shi L; Ji Q; Liu L
    Mediators Inflamm; 2021; 2021():6611085. PubMed ID: 33958974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of CACNA1H attenuates doxorubicin-induced acute cardiotoxicity by affecting endoplasmic reticulum stress.
    Hu J; Wu Q; Wang Z; Hong J; Chen R; Li B; Hu Z; Hu X; Zhang M
    Biomed Pharmacother; 2019 Dec; 120():109475. PubMed ID: 31580970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy.
    Zhang QL; Yang JJ; Zhang HS
    Biomed Pharmacother; 2019 Jan; 109():71-83. PubMed ID: 30396094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trehalose alleviates doxorubicin-induced cardiotoxicity in female Swiss albino mice by suppression of oxidative stress and autophagy.
    Abu-Khudir R; Ibrahim WM; Shams ME; Salama AF
    J Biochem Mol Toxicol; 2021 Sep; 35(9):e22859. PubMed ID: 34328254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LCN2 deficiency ameliorates doxorubicin-induced cardiomyopathy in mice.
    Jang HM; Lee JY; An HS; Ahn YJ; Jeong EA; Shin HJ; Kim KE; Lee J; Koh JS; Roh GS
    Biochem Biophys Res Commun; 2022 Jan; 588():8-14. PubMed ID: 34933182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin.
    Yokoyama C; Aoyama T; Ido T; Kakino A; Shiraki T; Tanaka T; Nishigaki K; Hasegawa A; Fujita Y; Sawamura T; Minatoguchi S
    PLoS One; 2016; 11(5):e0154994. PubMed ID: 27195769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of TRPA1 Attenuates Doxorubicin-Induced Acute Cardiotoxicity by Suppressing Oxidative Stress, the Inflammatory Response, and Endoplasmic Reticulum Stress.
    Wang Z; Wang M; Liu J; Ye J; Jiang H; Xu Y; Ye D; Wan J
    Oxid Med Cell Longev; 2018; 2018():5179468. PubMed ID: 29682158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroxine Alleviates Energy Failure, Prevents Myocardial Cell Apoptosis, and Protects against Doxorubicin-Induced Cardiac Injury and Cardiac Dysfunction via the LKB1/AMPK/mTOR Axis in Mice.
    Wang Y; Zhu S; Liu H; Wei W; Tu Y; Chen C; Song J; Li J; Sun S; Wang C; Xu Z
    Dis Markers; 2019; 2019():7420196. PubMed ID: 31929843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IKKα-STAT3-S727 axis: a novel mechanism in DOX-induced cardiomyopathy.
    Chen G; Yao Y; Liu Y; Zhang R; Wen C; Zhou Q; Xu Y; Wang W; Jiang H; Tao Z; Chen W; Qiu Z; Chen X
    Cell Mol Life Sci; 2024 Sep; 81(1):406. PubMed ID: 39287798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senescence marker protein 30 has a cardio-protective role in doxorubicin-induced cardiac dysfunction.
    Miyata M; Suzuki S; Misaka T; Shishido T; Saitoh S; Ishigami A; Kubota I; Takeishi Y
    PLoS One; 2013; 8(12):e79093. PubMed ID: 24391705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-12p35 Deficiency Reverses the Th1/Th2 Imbalance, Aggravates the Th17/Treg Imbalance, and Ameliorates Atherosclerosis in ApoE-/- Mice.
    Huang Y; Hu H; Liu L; Ye J; Wang Z; Que B; Liu W; Shi Y; Zeng T; Shi L; Ji Q; Chang C; Lin Y
    Mediators Inflamm; 2019; 2019():3152040. PubMed ID: 31093011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.